Samsara Bio Capital, LLC Nkarta, Inc. Transaction History
Samsara Bio Capital, LLC
- $173 Million
- Q3 2024
A detailed history of Samsara Bio Capital, LLC transactions in Nkarta, Inc. stock. As of the latest transaction made, Samsara Bio Capital, LLC holds 3,768,035 shares of NKTX stock, worth $9.42 Million. This represents 9.87% of its overall portfolio holdings.
Number of Shares
3,768,035
Previous 3,768,035
-0.0%
Holding current value
$9.42 Million
Previous $22.3 Million
23.52%
% of portfolio
9.87%
Previous 11.45%
Shares
5 transactions
Others Institutions Holding NKTX
# of Institutions
129Shares Held
66.5MCall Options Held
173KPut Options Held
20K-
Ra Capital Management, L.P. Boston, MA10.8MShares$27 Million0.68% of portfolio
-
Commodore Capital LP New York, NY4.66MShares$11.7 Million1.79% of portfolio
-
Black Rock Inc. New York, NY4.06MShares$10.1 Million0.0% of portfolio
-
Boxer Capital, LLC San Diego, CA4.03MShares$10.1 Million0.97% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.6MShares$9 Million0.03% of portfolio
About Nkarta, Inc.
- Ticker NKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,656,800
- Market Cap $122M
- Description
- Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...